175 related articles for article (PubMed ID: 1363649)
1. Clonal analysis of agnogenic myeloid metaplasia.
Kreipe H; Jaquet K; Felgner J; Parwaresch MR
Leuk Lymphoma; 1992 Dec; 8(6):459-64. PubMed ID: 1363649
[TBL] [Abstract][Full Text] [Related]
2. Clonal granulocytes and bone marrow cells in the cellular phase of agnogenic myeloid metaplasia.
Kreipe H; Jaquet K; Felgner J; Radzun HJ; Parwaresch MR
Blood; 1991 Oct; 78(7):1814-7. PubMed ID: 1680495
[TBL] [Abstract][Full Text] [Related]
3. Agnogenic myeloid metaplasia: a clonal proliferation of hematopoietic stem cells with secondary myelofibrosis.
Jacobson RJ; Salo A; Fialkow PJ
Blood; 1978 Feb; 51(2):189-94. PubMed ID: 620081
[TBL] [Abstract][Full Text] [Related]
4. Circulating haemopoietic progenitor cells in primary and secondary myelofibrosis: relation to collagen and reticulin fibrosis.
Colović MD; Wiernik PH; Janković GM; Vidović AD; Janosević S; Basara NM
Eur J Haematol; 1999 Mar; 62(3):155-9. PubMed ID: 10089892
[TBL] [Abstract][Full Text] [Related]
5. TGF-beta and megakaryocytes in the pathogenesis of myelofibrosis in myeloproliferative disorders.
Martyré MC
Leuk Lymphoma; 1995 Dec; 20(1-2):39-44. PubMed ID: 8750621
[TBL] [Abstract][Full Text] [Related]
6. Bone marrow histopathology and biological markers as specific clues to the differential diagnosis of essential thrombocythemia, polycythemia vera and prefibrotic or fibrotic agnogenic myeloid metaplasia.
Michiels JJ
Hematol J; 2004; 5(2):93-102. PubMed ID: 15048058
[TBL] [Abstract][Full Text] [Related]
7. [Histopathology and molecular pathology of chronic myeloproliferative disorders].
Kreipe HH
Veroff Pathol; 1993; 141():1-158. PubMed ID: 8372486
[TBL] [Abstract][Full Text] [Related]
8. Morphometric analysis of myelofibrosis in agnogenic myeloid metaplasia and chronic myelogenous leukemia.
Ohsaka A; Miura Y; Takahashi A; Yokoyama T
Virchows Arch B Cell Pathol Incl Mol Pathol; 1991; 60(6):399-405. PubMed ID: 1683056
[TBL] [Abstract][Full Text] [Related]
9. Increased erythrocytic and neutrophilic progenitors in myelofibrosis with myeloid metaplasia.
Ohl S; Carsten AL; Chanana AD; Chikkappa G; Cronkite EP
Eur J Cancer (1965); 1976 Feb; 12(2):131-5. PubMed ID: 1063073
[No Abstract] [Full Text] [Related]
10. Blastic phase of agnogenic myeloid metaplasia simulating malignant lymphoma.
Cehreli C; Ezdinli EZ; Li CY; Krmpotic E
Cancer; 1976 Sep; 38(3):1297-305. PubMed ID: 953969
[TBL] [Abstract][Full Text] [Related]
11. Current perspective in agnogenic myeloid metaplasia.
Tefferi A; Silverstein MN
Leuk Lymphoma; 1996 Sep; 22 Suppl 1():169-71. PubMed ID: 8951788
[TBL] [Abstract][Full Text] [Related]
12. Primary (essential) thrombocythemia versus initial (hyperplastic) stages of agnogenic myeloid metaplasia with thrombocytosis--a critical evaluation of clinical and histomorphological data.
Thiele J; Zankovich R; Steinberg T; Kremer B; Fischer R; Diehl V
Acta Haematol; 1989; 81(4):192-202. PubMed ID: 2474228
[TBL] [Abstract][Full Text] [Related]
13. Detection of aberrant gene expression in CD34+ hematopoietic stem cells from patients with agnogenic myeloid metaplasia using oligonucleotide microarrays.
Jones LC; Tefferi A; Vuong PT; Desmond JC; Hofmann WK; Koeffler HP
Stem Cells; 2005 May; 23(5):631-7. PubMed ID: 15849170
[TBL] [Abstract][Full Text] [Related]
14. Progressive myelofibrosis in agnogenic myeloid metaplasia.
Lohmann TP; Beckman EN
Arch Pathol Lab Med; 1983 Nov; 107(11):593-4. PubMed ID: 6688716
[TBL] [Abstract][Full Text] [Related]
15. Myelofibrosis in chronic granulocytic leukaemia.
Clough V; Geary CG; Hashmi K; Davson J; Knowlson T
Br J Haematol; 1979 Aug; 42(4):515-26. PubMed ID: 289409
[TBL] [Abstract][Full Text] [Related]
16. Marrow fibrosis does not account for circulating CD34+ cells in myelofibrosis with myeloid metaplasia.
Samuelson SJ; Popat U; Prchal JT
Haematologica; 2007 Apr; 92(4):e47. PubMed ID: 17405759
[No Abstract] [Full Text] [Related]
17. Cytogenetic and molecular genetic abnormalities in agnogenic myeloid metaplasia.
Reilly JT
Semin Oncol; 2005 Aug; 32(4):359-64. PubMed ID: 16202681
[TBL] [Abstract][Full Text] [Related]
18. Clonality in chronic myeloproliferative disorders defined by X-chromosome linked probes: demonstration of heterogeneity in lineage involvement.
Tsukamoto N; Morita K; Maehara T; Okamoto K; Sakai H; Karasawa M; Naruse T; Omine M
Br J Haematol; 1994 Feb; 86(2):253-8. PubMed ID: 7911034
[TBL] [Abstract][Full Text] [Related]
19. Increased granulocytic, erythrocytic, and megakaryocytic progenitors in myelofibrosis with myeloid metaplasia.
Chikkappa G; Carsten AL; Chanana AD; Chandra P; Cronkite EP
Am J Hematol; 1978; 4(2):121-31. PubMed ID: 677118
[TBL] [Abstract][Full Text] [Related]
20. Quantitative analysis of growth factor production in the mechanism of fibrosis in agnogenic myeloid metaplasia.
Wang JC; Chang TH; Goldberg A; Novetsky AD; Lichter S; Lipton J
Exp Hematol; 2006 Dec; 34(12):1617-23. PubMed ID: 17157157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
